Protective effect of bone marrow mesenchymal stem cells in intestinal barrier permeability after heterotopic intestinal transplantation

Table 3 Levels of graft diamine oxidase and D-lactic acid following heterotopic intestinal transplantation

	Group	D 1	D 3	D 5	D 7	D 10
DAO (U/mL)	A	10.15 ± 1.10	12.86 ± 1.35	15.76 ± 1.33	18.55 ± 1.77	21.83 ± 1.21
	B	22.36 ± 2.82a	34.74 ± 5.59a	44.54 ± 2.77a	51.61 ± 1.70a	68.02 ± 2.46a
	C	18.69 ± 2.17c	29.79 ± 2.49c	36.15 ± 3.98c	40.13 ± 1.21c	59.87 ± 4.34c
D-LA (g/L)	A	4.12 ± 0.53	6.13 ± 0.57	8.62 ± 1.67	10.78 ± 0.72	11.67 ± 1.56
	B	6.32 ± 0.46a	8.65 ± 0.62a	10.46 ± 0.98a	12.74 ± 0.68a	17.74 ± 1.75a
	C	3.08 ± 0.32c	4.08 ± 0.30c	5.031 ±0.18c	7.25 ± 0.51c	12.81 ± 0.47c

All values are mean ± SD (n = 6). A: Non-rejection group; B: Rejection group; C: Bone marrow mesenchymal stem cells therapy group.

^aP < 0.05 vs group A;

^cP < 0.05 vs group B. DAO: Diamine oxidase; D-LA: D-lactic acid.